Reference
Visentin A, et al. Ibrutinib in relapsed hairy cell leukemia variant: A case report and review of the literature. Hematological Oncology 38: 823-826, No. 5, Dec 2020. Available from: URL: http://doi.org/10.1002/hon.2810
Rights and permissions
About this article
Cite this article
Ibrutinib. Reactions Weekly 1843, 193 (2021). https://doi.org/10.1007/s40278-021-91295-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-91295-9